Eli Lilly and Company (LLY) Q2 2026 Preview: EPS Est. $6.55, Reports August 5
AlphaStreet Newsdesk powered by AlphaStreet Intelligence Related Coverage LLY|EPS Est $6.55 (21 analysts)|Rev Est $20.69B|Reports 2026-08-05 Midday Wall Street expects ...
Wednesday, August 5, 2026
Tag: Lilly
Eli Lilly: Perfektes Pullback-Setup nach Rekordjagd!
Pharmagigant an charttechnischer Schlüsselmarke! Rückblick Nach einer längeren Konsolidierungsphase bis Ende April startete die Aktie einen dynamischen Aufwärtstrend. Eli Lilly ...
Eli Lilly: Pharma-Gigant greift nach der Billionen-Dollar-Krone!
Zwischen astronomischem Wachstum und charttechnischem Momentum! Rückblick Die Story von Eli Lilly lässt sich im Moment in drei Buchstaben zusammenfassen: ...
Jefferies Remains a Buy on Eli Lilly and Company (LLY)
Eli Lilly and Company (NYSE:LLY) is one of the Good Stocks to Buy Now. On March 20, Jefferies reiterated a ...
RBC Capital Initiates Eli Lilly (LLY), Cites Long-Term Leadership in Obesity Market
Eli Lilly and Company (NYSE:LLY) is included among the 14 Best GARP Stocks to Buy According to Analysts. On February ...
Up 36%, Is Eli Lilly Still a Buy?
Eli Lilly is at the forefront of both diabetes and obesity medications. The pharmaceutical giant has offered strong guidance for ...
BMO Reaffirms Eli Lilly and Company (LLY) as an Obesity Market Leader
Eli Lilly and Company (NYSE:LLY) is among the stocks with the best earnings growth for the next 5 years. On ...
Eli Lilly – LLY: Kursfantasie dank Medikamenten-Boom!
Starke Wachstumsprognosen! Analysten sehen weiter großes Potenzial bei Eli Lilly (LLY): Knackiges Breakout-Setup! Eli Lilly (LLY) – ISIN US5324571083 Rückblick: ...
-1024x683.jpg "El-Sayed Wins Dem Nomination in Michigan")
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.